YadwinderSinghDhillonMD

Associate Proffesor University of Arizona Physician Executive Director Wound and Reconstructive Institute Banner University Medical Center- Phoenix

Dr. Dhillon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1450 S Dobson Rd
Ste 122B
Mesa, AZ 85202
Phone+1 602-314-4432

Fax+1 602-324-2308

Creighton University School of Medicine (Phoenix)Residency, Family Medicine, 2006 - 2009
Dayanand Medical College Class of 2004

PubMed

Abstracts/Posters

The Use of Total Contact Casting to Facilitate Wound Closure in Non-ambulatory Patients. Poster presented at the Symposium on Advanced Wound Care; Denver, CO. May 1-5,...
Dhillon, Y; Altamirano, D; Hall, A., SAWC
Flowable Wound Matrix in Difficult to Heal Pressure Ulcers. Poster presented at the Symposium on Advanced Wound Care; Denver, CO. May 1-5, 2013.
Dhillon, Y; Altamirano, D; Hall, A., SAWC
Hyperbaric Oxygen Therapy for the Treatment of Arterial Gas Emboli. Poster presented at The 46th Undersea & Hyperbaric Medical Society Annual Scientific Meeting; O...
Yngelmo, E; Gill, P; Dhillon, Y., UHMS
Hyperbaric Oxygen Therapy for the Treatment of Acute Arterial Insufficiency Due to Reflex Sympathetic Dystrophy. Poster presented at The 46th Undersea & Hyperbaric...
Yngelmo, E; Gill, P; Dhillon, Y., UHMS
Join now to see all

Principal InvestigatorPrincipal Investigator: Hi-Tide- Phase 3 diabetic foot ulcer clinical trial (NCT04457752) Wagner Grade 3 DM foot ulcer
Principal InvestigatorPrincipal Investigator: Mallinckrodt- Phase 2 C9T12015 Express Graft safty on diabetic foot ulcer, Wagner grade 3 and above.
Principal InvestigatorPrincipal Investigator: Smith and Nephew- Phase 3 clinical trial. Grafix in non healing chronic venous wound.
Principal InvestigatorPrincipal Investigator: Healthpoint: A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer
Principal InvestigatorPrincipal Investigator: Healthpoint: A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Principal InvestigatorPrincipal Investigator: Healthpoint: A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to 36 cm2
Principal InvestigatorPrincipal Investigator: Smith and Nephew- A multi center, prospective, clinical in market evaluation of PICO use on chronic and open wound
Principal investigatorPrincipal Investigator: Department of Defense- The Impact of Hyperbaric Oxygen Therapy on the Wound Microbiome, Wound Host-Microbe Interaction, and Patient Outcomes.